- What they do
- Cerevance is a biotechnology company developing therapies for neurodegenerative disorders and central nervous system diseases. The company uses its proprietary NETSseq platform to identify novel drug targets and advance cell type-specific therapeutic candidates through clinical development.Taken from the employer’s own website. This is the company describing itself, not something we have verified.
- Approximate size
- Files full accountsFrom the accounts category filed at Companies House, not a headcount.
- Founded
- 29 July 2016Date of incorporation at Companies House, which is not always when trading began.
- Registered office
- 418 CAMBRIDGE SCIENCE PARK, CAMBRIDGE, CB4 0PZ, UNITED KINGDOMThe address registered at Companies House. It is often an accountant’s office rather than a workplace.
- Filings
- Up to date, next due 31 December 2026Accounts last made up to 31 December 2024.